ISSN Imprimir: 2151-805X
Volumes:Volume 10, 2019 Volume 9, 2018 Volume 8, 2017 Volume 7, 2016 Volume 6, 2015 Volume 6, 2015 Volume 5, 2014 Volume 5, 2014 Volume 5, 2014 Volume 5, 2014 Volume 4, 2013 Volume 4, 2013 Volume 4, 2013 Volume 4, 2013 Volume 3, 2012 Volume 3, 2012 Volume 2, 2011 Volume 2, 2011 Volume 2, 2011 Volume 2, 2011 Volume 1, 2010 Volume 1, 2010 Volume 1, 2010 Volume 1, 2010
Ethics in Biology, Engineering and Medicine: An International Journal
Pain Medicine, Biotechnology, and Market Effects: Tools, Tekne, and Moral Responsibility
Departments of Neurology and Biochemistry, and the Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, D.C.
Tanabe Research Labs USA, 4540 Towne Centre Court, San Diego, California 92121
Mark V. Boswell
Department of Anesthesiology and Perioperative Medicine, University of Louisville School of Medicine, Louisville, KY, 40202 , USA
Despite advances in neurotechnology, pain remains a subjective experience that cannot be identified solely through objective means. The technological turn has led to and been synergized by market effects within medicine. In this paper we pose that this has led to 1) sidestepping of the discriminative intellectual integrity of science to inform and sustain the good of medicine, 2) diversion and/or subversion of physicians’ capacity to make wellinformed clinical decisions, 3) the excessive use (if not misuse) of certain technologies and technologically-based techniques, 4) a compromised 'discretionary space' in which physicians may use technology to uphold patients' best interest(s) and 5) a decremented medical fiduciary. In response, we propose four principal goals that could enable a more integrative use of technology. These are 1) promotion of 'customary' and 'out of the box' basic and clinical science as needed for new technologies in more personalized therapeutic settings and regimes, 2) eliminating unnecessary, inapt or inconsequential use(s) of technology, 3) development and provision of healthcare coverage that enables use of high technology as necessary and appropriate, and 4) incorporation of this insurance system within a broad Samaritan ethic of care.
|Portal Digital Begell||Biblioteca digital da Begell||eBooks||Diários||Referências e Anais||Coleções de pesquisa|